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Abstract
This article considers the problem of estimating a multivariate probit model in a
panel data setting with emphasis on sampling a high-dimensional correlation matrix and
improving the overall efficiency of the data augmentation approach. We reparameterise
the correlation matrix in a principled way and then carry out efficient Bayesian inference
using Hamiltonian Monte Carlo. We also propose a novel antithetic variable method to
generate samples from the posterior distribution of the random effects and regression
coefficients, resulting in significant gains in efficiency. We apply the methodology by
analysing stated preference data obtained from Australian general practitioners evaluating
alternative contraceptive products. Our analysis suggests that the joint probability of
discussing long acting reversible products with a patient shows medical practice variation
among the general practitioners, which indicates some resistance to even discussing these
products, let alone recommending them.
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1 Introduction
Bayesian inference for the multivariate probit (MVP) model is usually performed using the
data augmentation representation of Chib and Greenberg (1998), whereby the latent variables
indicating the observed outcomes are normally distributed. For unique identification of the
regression parameters, the covariance matrix of these latent normal random variates is assumed
to be a correlation matrix R. However, Monte Carlo sampling for R in a Bayesian context is
difficult due to restrictions on the diagonal entries and the requirement that the matrix R
must be positive definite.
This article presents three contributions, two methodological and the third a subject matter
one. The first methodological contribution provides an improved method for sampling the
potentially high dimensional correlation matrixR within a Markov chain Monte Carlo (MCMC)
algorithm. In order to circumvent the positive definiteness restriction imposed on a correlation
matrix, we adopt the reparameterisation strategy of Smith (2013) which re-expresses R as an
unconstrained Cholesky factor L. This mapping transforms the confined space of a correlation
matrix to a Cartesian space, which improves posterior simulation while keeping the number
of parameters to be estimated the same. A prior distribution is then specified on L such
that the implied marginal densities of the correlation coefficients are uniform on [−1, 1]. We
employ the Hamiltonian Monte Carlo (HMC) algorithm (Neal, 2011) to sample the high
dimensional L efficiently, thereby avoiding the slow exploration of parameter space by random
walk updates as in Smith (2013). Although enjoying a high popularity in recent years in the
MVP model literature (Liu, 2001; Talhouk et al., 2012), our empirical results demonstrate
that the parameter expansion strategy (Liu and Wu, 1999; van Dyk and Meng, 2001) does not
trivially extend to the panel data setting.
Our second methodological contribution is to introduce antithetic sampling, based on the
work of Hammersley and Morton (1956), into the Metropolis-Hastings (MH) literature. In
order to implement this idea, we specify the proposal distribution of parameter update as
a deterministic function. Here, the generated samples will be super-efficient in terms of the
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reduction in variance of the Monte Carlo estimates compared to the same estimates constructed
from uncorrelated samples. Although the chain update proposal is deterministic, convergence
properties are not compromised when this is embedded within a larger system of MCMC
sampling. We note that a similar idea was proposed by Pakman and Paninski (2014), although
the resulting improvement in efficiency is not prominent in their framework. Our proposal
here is different from theirs in two ways. First, we do not restrict the posterior distribution to
be normal, but rather require it to be symmetric only. Second, we introduce perfect negative
correlation between successive MCMC samples via the deterministic proposal while Pakman
and Paninski (2014) suggest generating independent samples. Results based on our real data
application document a significant improvement of up to 3.75 times performance gain in the
mixing behaviour of the Markov chain, thereby lowering autocorrelation between samples.
Computing time of the algorithm is also marginally reduced due to the deterministic sampling.
Our methodological development is motivated by the staged stated preference panel data
collection described in Fiebig et al. (2017), which is used to study the decision-making of
Australian general practitioners (GPs) about female contraceptive products. Here, the authors
used the data from the third and final stage whereas we explore outcomes from the second
stage. This second stage relates to the question of which particular contraceptive products
GPs would discuss with a female patient, defined by a vignette that is part of the experimental
design. Analysing these product choices univariately would ignore possible complex dependence
structures that are useful in exploring which particular bundles of products are discussed with
patients. This is important here because in any correlated choice problems there may be
multiple close substitutes, which makes joint rather than marginal probabilities more relevant.
Therefore, we model the GPs’ choices by a MVP model. Inspection of the resulting graphical
model describing this interaction between products lends support to the suitability of a
multivariate approach. By using the MVP model, we are able to compute the joint probability
of specific product bundles being discussed with a patient. Posterior estimation of this
probability, based on a patient with certain socio-economics and clinical characteristics, reveals
differing views among the GPs in the sample on the suitability of long acting contraceptive
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choices. This variability is known as medical practice variation in the health industry, whereby
the decision making of GPs is influenced by both their personal characteristics such as gender,
age and qualifications, and other unobservables that we model as random effects.
This paper is organised as follows. Section 2 describes the MVP model with random effects
and reviews previous research associated with sampling high-dimensional correlation matrices.
Section 3 presents our proposed methodology of sampling a high dimensional correlation matrix
and the antithetic sampling technique. Section 4 provides our analysis of the discussion prefer-
ence data of contraceptive products by Australian GPs, and Section 5 concludes. Appendix A
investigates the extension of the parameter expansion strategy to the panel data setting, while
Appendices B–G provide further details on the contraceptive product data analysis.
2 Multivariate probit model with random effects
The MVP model has been used extensively to model correlated binary data (Gibbons and
Wilcox-Go¨k, 1998; Buchmueller et al., 2013). Let yit = (y1,it, . . . , yD,it)
> be a vector of D
correlated binary outcomes for individual i = 1, . . . , P at time period t, for t = 1, . . . , T . The
latent variable representation of the MVP model, using the data augmentation approach of
Albert and Chib (1993), is given by
y∗it = αi +Bxit + it, (2.1)
αi = (α1,i, . . . , αD,i)
> iid∼ N (0,Σα), (2.2)
it = (1,it, . . . , D,it)
> iid∼ N (0,R), (2.3)
for i = 1, . . . , P, t = 1, . . . , T where y∗it = (y
∗
1,it, . . . , y
∗
D,it)
> is a (continuous) latent variable, αi
is a D-vector of outcome-specific random effects for individual i allowing for heterogeneity
between individuals, xit = (1, x1,it, . . . , xK−1,it)> is an exogenous variable, B is a D × K
matrix of regression coefficients and it is a D-vector correlated error term which models the
dependence structure between outcomes. The variable xit is assumed to be uncorrelated with
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both αi and it. This is entirely appropriate in the stated preference case that is our motivating
analysis but relaxing the assumption of exogenous xit represents a useful extension. In order
for B to be uniquely identified (Chib and Greenberg, 1998), R is set to be a correlation
matrix. The observed outcome yit is defined to be dependent on the sign of the latent variable
y∗it via the relationship
yd,it = 1(y
∗
d,it > 0), d = 1, . . . , D, (2.4)
where 1(E) is an indicator function which takes value 1 if the event E occurs and 0 otherwise.
Let y = {yit; i = 1, . . . , P, t = 1, . . . , T} be the set of observed discrete outcomes. The
likelihood function of the MVP model conditional on the random effects α1:P = (α1, . . . ,αP )
based on the formulation in (2.1)–(2.4) is then given by
p(y∗|α1:P ,θ) =
P∏
i=1
T∏
t=1
φ(y∗it;µit,R), (2.5)
where y∗ is the latent variable for data y, µit = αi +Bxit and φ is the multivariate normal
density function.
2.1 Prior choice for the correlation matrix R
Following the specification of the MVP model in (2.1)–(2.4), the posterior density is
pi(y∗,α1:P ,θ|y) = p(y|y
∗,α1:P ,θ)p(y∗|α1:P ,θ)p(α1:P |θ)p(θ)
p(y)
, (2.6)
where p(y) is the marginal likelihood, p(θ) is the prior on the model parameters θ = (B,R,Σα)
and
p(y|y∗,α1:P ,θ) =
P∏
i=1
T∏
t=1
D∏
d=1
(
1(yd,it = 0)1(y
∗
d,it ≤ 0) + 1(yd,it = 1)1(y∗d,it > 0)
)
. (2.7)
Useful conjugate priors are available for B (or β = vec(B)) and Σα which simplifies MCMC
sampling, but it is difficult to posit a suitable prior for R.
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Barnard et al. (2000) decompose a covariance matrix into diagonal matrices of standard
deviations and correlation matrix to obtain a prior distribution on R as
p(R) ∝ |R| 12 (ν−1)(D−1)−1
(
D∏
i=1
|R(−i;−i)|
)− ν
2
, (2.8)
where ν is the degrees of freedom and R(−i;−i) denotes the i-th principal submatrix of R,
that is with the i-th row and column removed. They show that the above prior induces a
modified Beta distribution on each off-diagonal element rij of R, i 6= j. In particular, the
marginal densities of the rij are uniform on [−1, 1] when ν = D+1, which means that posterior
inference is invariant to the ordering of the binary outcomes y.
We now discuss related work on the prior forR. LetRD be the space of all valid correlation
matrices. Barnard et al. (2000) also suggest a uniform prior over all correlation matrices in
RD, but its density is greater around zero for each rij in high dimensions and is thus highly
informative. This prior is also a particular instance of the LKJ prior of Lewandowski et al.
(2009) with unit shape parameter, as suggested by the Stan Development Team (2017). Chib
and Greenberg (1998) propose using a multivariate normal prior on the rij , with the support of
the prior restricted to values of rij which give a correlation matrix in RD, while Liechty et al.
(2004) introduce a mixture of normal distributions prior on rij to express a priori knowledge of
blocked structure in R. However, these choices of normal priors do not imply that all marginal
densities of the rij are the same due to the constraints imposed on the rij for the resulting R
to be in RD. Therefore, we adopt the prior (2.8) in our article because of its properties of
being marginally uninformative on the rij and also order invariant to y for ν = D + 1.
2.2 Posterior sampling of R
Posterior simulation for R is challenging for two reasons: (i) the diagonal elements of R must
be 1 and, (ii) R must be positive definite. Chib and Greenberg (1998) suggest sampling the
rij elements of R in blocks using a random walk Metropolis-Hastings (RWMH) algorithm with
a multivariate t proposal density. However, the resulting matrix obtained after each proposal
6
is not guaranteed to be a valid correlation matrix in addition to the RWMH algorithm being
notorious for its slow exploration of the parameter space. Tuning the parameters of this proposal
distribution also requires finding an approximate mode of the log posterior distribution and
the observed Fisher information for every iteration, resulting in high computational overheads.
In the setting of hierarchical regression models, Barnard et al. (2000) adopt the Griddy-Gibbs
sampler of Ritter and Tanner (1992) to sample R. Here, prior to the Gibbs step, one needs
to solve a quadratic equation to determine the support for a single rij (while keeping the rest
fixed) which results in a valid correlation matrix. The authors document the clear inefficiency
in this sampling scheme when the prior in (2.8) is used due to its tendency to place more
weight on the edges of RD space. Moreover, the design of drawing one rij at a time becomes
computationally prohibitive when D is large.
In recent years, one popular approach for sampling R for the MVP model is to employ
the parameter expansion strategy (Liu and Wu, 1999; van Dyk and Meng, 2001) in order to
reparameterise the constrained correlation matrix into an unconstrained covariance matrix.
Let Σ = DRD, where R has density (2.8) and D is a diagonal matrix with its entries
drawn from an inverse-Gamma distribution. Talhouk et al. (2012) show that Σ follows an
inverse-Wishart IW(ν, I) distribution with degrees of freedom ν and scale matrix the identity
matrix I. Treating D as a working parameter, and since the inverse-Wishart distribution on
Σ is a conjugate prior in the parameter expanded model, posterior sampling of Σ can be
accomplished easily by Gibbs sampling from the full conditional. A realisation of R is then
obtained by normalising Σ. This method was first developed by Liu (2001) and Lawrence et al.
(2008) but using different priors on R. Different variants of the parameter expansion strategy,
including an MH accept-reject step for the proposed correlation matrix, can be found in Liu
and Daniels (2006) and Zhang et al. (2006). However, our empirical results show that the
parameter expansion method does not work in the setting of the MVP model in the presence of
random effects when we alternate between sampling R in the parameter expanded model and
α1:P from its full conditional posterior. In particular, the elements of the covariance matrix Σα
do not converge to the correct posterior distributions (see Appendix A for a demonstration).
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3 Efficient sampling for R when using a marginally
uniform prior
In this section, we describe an efficient way of sampling R by utilising Hamiltonian dynamics
(Duane et al., 1987). This firstly involves reparameterising R to enable sampling of parameters
in an unconstrained space. We then proceed by generating samples with greater efficiency
than independent samples using the ideas of antithetic variables. In this case, the proposal for
the parameter updating is set deterministically.
Due to the attractive properties of the prior p(R) in (2.8) being invariant to different
ordering of the outcome vector y and being marginally uniform on the rij when ν = D+ 1, we
will use this prior hereafter. Updates for y∗, α1:P , β and Σα can be performed easily in Gibbs
style (see Geweke (1991) and Chapter 10 of Greenberg (2012) for details), so our focus is on
the following non-standard conditional posterior distribution
pi(R|y,y∗,α1:P ,θ−R) ∝
P∏
i=1
T∏
t=1
φ(y∗it;µit,R) · p(R), (3.1)
where θ−S is defined as θ, but excluding the parameters S.
3.1 An unconstrained parameterisation
Because of the restrictions on sampling correlation coefficients on a confined space, we adopt
the reparameterisation strategy in Smith (2013) which re-expresses R via a positive definite
matrix Σ as
R = Λ
−1/2
 ΣΛ
−1/2
 , (3.2)
where Λ = diag(Σ). The covariance matrix Σ can then be written in terms of its Cholesky
factorisation Σ = LL> where L is a lower triangular matrix. The diagonal elements of
L are set as 1 so that the transformation of R to L is one-to-one. We define an operator
vechL which vectorises the strict lower triangle of a matrix by row. The unknown parameter
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vechL(L) = {Lij; i = 2, . . . , D, j < i} is now unconstrained and encompasses the whole real
line. Lindstrom and Bates (1988) also implement the Cholesky factorisation on a covariance
matrix to optimise the log-likelihood function of a linear mixed effects model. Other possible
reparameterisation methods for R include using polar coordinates (Rapisarda et al., 2007)
and partial autocorrelations (Daniels and Pourahmadi, 2009) but we adopt the representation
in (3.2) due to its computational tractability.
By using a change of variables, we can rewrite the density function in (3.1) in terms of
vechL(L) as
pi(vechL(L)|y,y∗,α1:P ,θ−L) ∝ pi(R|y,y∗,α1:P ,θ−R) · |J|, (3.3)
where |J| = |∂vechL(R)/∂vechL(L)>| is the determinant of the Jacobian for the transforma-
tion. We note here that for the transformation from R to L, the prior on lower triangular
Cholesky factor L whose diagonal entries are all fixed as ones, given by
p(vechL(L)) ∝ p(R) · |J|, (3.4)
induces a marginally uniform prior on all rij.
3.2 Sampling the Cholesky factor using HMC
HMC, popularised by Neal (2011), has enjoyed considerable recent interest within the statistical
literature due to its ability to generate credible but distant candidate parameters for the MH
algorithm, thereby reducing autocorrelation in the posterior samples. It does so by exploiting
gradient information of the log posterior density to simulate a trajectory according to physical
dynamics.
Given a target distribution of interest pi(ϑ), which in our case is the density in (3.3), HMC
introduces a fictitious momentum variable u into the physical system, which is assumed to
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follow a N (0,M) pseudo-prior and targets the augmented distribution
pi(ϑ,u) ∝ exp(−H(ϑ,u)), (3.5)
where H(ϑ,u) = − log pi(ϑ) + 1
2
u>M−1u is termed the Hamiltonian which is made up of
potential energy and kinetic energy components. The potential energy is derived from minus
the log density of ϑ under the target distribution while the kinetic energy is due to the
movement of the momentum variable u. The Hamiltonian system is used to describe the
evolution of ϑ and u over time t via
dϑ
dt
=
∂H
∂u
and
du
dt
= −∂H
∂ϑ
. (3.6)
The dynamics in (3.6) can be implemented in practice using the leapfrog method (Neal, 2011)
and discretising continuous time by a stepsize ε so that
u(t+ ε/2) = u(t)− (ε/2)∂H
∂ϑ
(ϑ(t))
ϑ(t+ ε) = ϑ(t) + ε
∂H
∂u
(u(t+ ε/2))
u(t+ ε) = u(t+ ε/2)− (ε/2)∂H
∂ϑ
(ϑ(t+ ε)).
(3.7)
Neal (2011) shows that properties of the Hamiltonian such as reversibility and volume preser-
vation are maintained under the symplectic integrator in (3.7). Proposed values ϑnew and unew
obtained after a trajectory length of T = nε by iterating procedures in (3.7) n times are then
accepted with probability min{1, exp(H(ϑ,u)−H(ϑnew,unew))}. The invariant distribution
of the Markov chain generated from the HMC algorithm is pi(ϑ,u) and samples from pi(ϑ) can
be obtained by marginalising out the momentum u. In order to implement the HMC algorithm
as described above, computation of the differential of (3.3) with respect to Lij is required for
the leapfrog update. Lemma 1 presents the derivatives required for the computation of the
gradient. Its proof is straightforward and therefore omitted. See Chapter 8 of Magnus and
Neudecker (1999) for details.
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Lemma 1. For the parameterisation of R in (3.2),
1.
∂R−1
∂Lij
= −Λ1/2
(
Σ−1
∂Σ
∂Lij
Σ−1 +
∂Λ
−1/2

∂Lij
Λ1/2 Σ
−1
 + Σ
−1
 Λ
1/2

∂Λ
−1/2

∂Lij
)
Λ1/2 .
2.
∂ log |R|
∂Lij
= tr
(
Σ−1
∂Σ
∂Lij
)
− 2Lij∑i
k=1 L
2
ik
.
3.
∂ log |R(−k;−k)|
∂Lij
= tr
(
R−1 (−k;−k)E>k
∂R
∂Lij
Ek
)
, where Ek denotes the matrix ob-
tained by removing column k from an identity matrix I.
3.3 A deterministic proposal based on an antithetic variable
The inefficiency of the MCMC algorithm in estimating the expectation E[f(ϑ)] of a scalar
function f(ϑ) of ϑ with respect to some posterior distribution pi(ϑ) is usually measured by
the integrated autocorrelation time (Roberts and Rosenthal, 2009), which is defined as
IACTf = 1 +
∞∑
j=1
ρj,f , (3.8)
where ρj,f is the lag j autocorrelation function of the MCMC iterates of f(ϑ) after convergence.
A small value of the IACT is desirable in practice as it indicates that the Markov chain mixes
well. We note that the IACT can be less than 1 if some of the autocorrelations are negative, in
which case a Monte Carlo estimator constructed from these samples would be super-efficient.
In order to take advantage of this property, we introduce a deterministic design of the proposal
distribution for ϑ
q(ϑnew|ϑ) = δψ(ϑ)(ϑnew), (3.9)
where ψ is a mapping function which introduces negative correlation between samples and
δψ(ϑ) is the Dirac delta function at ψ(ϑ). In this case, the MH acceptance probability involves
the ratio of pi(ϑ) evaluated at ϑnew and ϑ.
For any symmetric probability distribution pi(ϑ), we propose setting
ψ(ϑ) = 2µϑ − ϑ, (3.10)
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where µϑ is the mean of pi(ϑ). The antithetic variable method is a Monte Carlo variance
reduction technique whereby error cancellation in the estimation of E[f(ϑ)] is obtained
by introducing negative correlation between samples. It is clear that (3.10) is such a case.
Symmetry of pi(ϑ) also indicates that pi(ϑnew) = pi(ϑ), which in turn translates to an acceptance
probability of one. Clearly, antithetic sampling will only yield an ergodic Markov chain when
it is coupled with stochastic simulation of additional parameters that affect the value of
the deterministic proposal ψ(ϑ). Under this condition, the value of µϑ changes in every
iteration of the MCMC update and this drives the exploration of ϑ in the parameter space.
Furthermore, the dependence between ϑ and other model parameters prevents exact periodicity
from occurring, and thus the Markov chain is aperiodic.
Note that similarly, the Hamiltonian proposal in (3.6) is also deterministic and the stochastic
component comes from the sampling of the momentum variables u. In fact, antithetic sampling
of normal random variables can also be understood in terms of a HMC update. Suppose
that ϑ ∼ N (µϑ,Σϑ), and the prior on momentum variable u is chosen to be N (0,Σ−1ϑ )
distributed. Pakman and Paninski (2014) show that the resulting Hamiltonian system can be
solved analytically, with solution given by
ϑ(t) = µϑ + Σϑu(0) sin(t) + (ϑ(0)− µϑ) cos(t), (3.11)
which is a linear combination of µϑ, the initial value ϑ(0) of ϑ and the initial momentum
u(0). Equation (3.11) is thus equivalent to the antithetic sample in (3.10) when setting the
trajectory length T for HMC as pi radians. Since there is no approximation error in the
Hamiltonian dynamics for a normal distribution, an MH accept-reject step is not required in
the HMC sampler, and the proposed value of ϑ will always be accepted. This equivalence
relation was first observed by Pakman and Paninski (2014), but was not particularly useful in
their framework of sampling from a truncated multivariate normal distribution. Our proposal
for antithetic sampling is different in the sense that it can be applied to the more general
setting of any symmetric distribution, and in the special case of a normal distribution, we
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choose T = pi radians to induce a perfect negative proposal correlation, whereas Pakman and
Paninski (2014) suggest an independent proposal by setting T = pi/2 radians.
3.4 Simulation studies
A simulated dataset is generated following the MVP model given in (2.1)–(2.4), with D =
8, P = 162, T = 16 and values of the parameter θ = (β,R,Σα) set to be the posterior
mean estimates of the parameters in Model 1 of the female contraceptive product analysis of
Section 4. In order to choose the tuning parameters for the HMC algorithm, we perform pilot
runs of the algorithm with trial values of stepsize ε and trajectory length T . Values of these
tuning parameters for the leapfrog integrator are then found by the pair of ε and T which gives
the smallest IACT values. As for the mass matrix M of the momentum variable u, we find
that using an identity mass matrix is computationally more efficient than settingM to be the
estimated precision matrix of vechL(L) for our problem. We use the following non-informative
prior distributions: β ∼ N (0, 100I), Σα ∼ IW(9, I) and the prior distribution on lower
triangular Cholesky factor L given in (3.4). The sampling scheme is run for 30 000 iterations,
with the first 5 000 samples discarded as burn-in.
We now study the efficiency of the antithetic variable technique described in Section 3.3
to sample the random effects α1:P and the regression parameter β. The full conditional
posterior distributions of α1:P and β are normal so the deterministic proposal update in (3.10)
can be implemented. Figure 3.1 compares graphically the marginal posterior densities and
sample autocorrelations of randomly sampled α1:P and β parameters between independent and
antithetic sampling. Despite the absence of a stochastic component in the updates of α1:P and
β, the kernel density plots of these parameters indicate that the coupling of a stochastic MCMC
scheme for the remaining parameters with the antithetic variable technique gives the same
posterior distributions as those under independent sampling. The autocorrelation plots show
that the samples generated from antithetic sampling have positive dependence with a higher
rate of decay over the number of lags, thereby demonstrating a superior mixing Markov chain.
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Figure 3.1: Marginal posterior densities of a randomly selected random effects term (top
panel) and regression coefficient (bottom panel), and their sample autocorrelation plots under
independent and antithetic sampling.
We also report the IACT which is computed using the coda package (Plummer et al., 2006).
The IACT values of the randomly sampled parameters are significantly lower, whereby an
improvement by a factor of 1.80 and 2.31 is observed for α3,80 and β180 respectively. Although
perfect negative correlation is induced between successive samples by the deterministic proposal,
this does not translate to an equivalent autocorrelation in the posterior samples. Rather, the
negative relationship is used to reduce the magnitude of positive autocorrelation present in
MCMC samples. Note that convergence to the posterior distribution might be slow for poorly
initialised values under antithetic sampling so we suggest using independent sampling during
the burn-in period and later switching to the deterministic proposal.
The remaining simulation experiments are constructed to investigate the performance of
the MVP model in the context of recovering the true parameters of the data generating process
under different specifications of prior distribution on θ. We use the posterior root-mean-square
error (RMSE) defined by
RMSE(θ) =
√√√√ 1
N
N∑
j=1
(θ[j] − θtrue)2, (3.12)
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as the performance measure, where θ[j] is the j-th iterate from the N posterior samples and
θtrue is the true value of θ. The measure in (3.12) is defined for univariate θ so an average of
the posterior RMSE is calculated for multivariate θ. All the results shown are based on 1 000
different replicate sets of simulated data with the same true parameter values.
We first consider the conditionally conjugate hierarchical inverse-Wishart HIW(λ,A)
prior of Huang and Wand (2013) with degrees of freedom λ and positive scale parameter
A = (A1, . . . , AD)
> as an alternative to the inverse-Wishart prior on the D ×D covariance
matrix Σα,
Σα|a1, . . . , aD ∼ IW
(
λ+D − 1, 2λdiag
(
1
a1
, . . . ,
1
aD
))
,
ai
iid∼ IG(0.5, A−2i ), i = 1, . . . , D,
(3.13)
where IG(γ, κ) is an inverse-Gamma distribution with shape γ and scale κ. The marginal prior
of the standard deviation σαi in Σα is a half-t(λ,Ai) distribution, as suggested in Gelman
(2006) while the correlation coefficient r(αi,αj) is marginally uniform on [−1, 1] when setting
λ = 2. In the simulation, we select λ = 2 and choose a weakly informative scale parameter
whereby A1 = A2 = 0.23 and A3 = · · · = A8 = 0.46 so that approximately 95% of the half-t
density is below 1 and 2 respectively. This is done to incorporate information that α1,i and α2,i
are less variable compared to the rest of the random effects terms. Although the hierarchical
inverse-Wishart prior is flexible enough to specify different strengths of prior on each of
the variance parameter σ2αi , Figure 3.2a shows that its performance is similar to the more
restrictive inverse-Wishart prior. This result is somewhat unsurprising considering that the σ2αi
are similar across the different contraceptive products in the real data considered in Section 4.
Furthermore, these variances are not extremely small or large so we do not encounter the bias
problems associated with using an inverse-Wishart prior discussed in Alvarez et al. (2014).
To identify sparse signals (coefficients which are significant) in the regression parameter β,
we employ the horseshoe shrinkage prior (Carvalho et al., 2010) given by
βi|λi, τ ∼ N (0, τ 2λ2i ), λi ∼ C+(0, 1), τ ∼ C+(0, 1), (3.14)
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where C+(0, 1) is a half-Cauchy distribution with location 0 and scale 1 restricted to positive
support. The simulation is carried out by setting 75% of the smallest non-intercept regression
coefficients (in absolute value) in β to 0, from which we generate the simulated datasets.
We model the prior on each intercept separately by a flat N (0, 100) distribution to avoid
heavily penalising these parameters. Gibbs sampling from the posterior distribution of β
is implemented by adopting the latent variable formulation in Makalic and Schmidt (2016).
Figure 3.2b displays the results. The horseshoe prior performs as well as the N (0, 100I) prior
on non-zero entries of β, although there is slightly more variability in the average posterior
RMSE. On the other hand, the horseshoe prior outperforms the normal prior for the parameters
whose true values are zero by recording an average posterior RMSE that is considerably lower.
This is because (3.14) places a greater density around zero, which results in a more concentrated
posterior distribution for parameters which are truly zero.
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(a) Posterior RMSE of σαi and r(αi,αj).
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(b) Posterior RMSE of zero and non-zero β.
Figure 3.2: Distributions of the average posterior RMSE of θ under different prior choices over
1 000 replications.
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4 Application: Discussion of female contraceptive
products by Australian GPs
4.1 Background and aims of study
In order to study the decision-making behaviour of Australian GPs, we obtain data from Fiebig
et al. (2017) who design a stated preference experiment in which GPs are asked to select the
contraceptive products that they would consider discussing with hypothetical female patients.
The GPs evaluate a sequence of vignettes where patients are defined in terms of socio-economic
and clinical characteristics that are varied as part of the experimental design. Table C.1 in
Appendix C contains the attributes of the patients with a description for each level of the
categorical variables. The GPs choose from a set of 9 products that they would discuss with
the patient before deciding upon their most preferred product to be subsequently prescribed
to the patient. A sample of 162 GPs participated in the experiment where each subject makes
choices for 16 different patients, resulting in 2 592 observations. Covariate information is
collected on the GPs themselves: age, gender, whether they are registered as a Fellow of the
Royal Australian College of GPs, whether they have a certificate in family planning, whether
they are an Australian medical graduate, whether their location of practice is in an urban
area and whether they bulk-bill patients. Analysis of these panel data is based on the set of
binary outcomes as to whether or not to discuss each of the contraceptive products. Due to
low occurrences for the prescription of the hormonal patch which was yet to be released in
the Australian market, we remove this product from the dataset leaving observations on the 8
remaining products.
The experiment is designed to mimic the choice problem faced by GPs in a consultation
where they need to match a product with a particular patient. In characterising such a decision
problem, Frank and Zeckhauser (2007) distinguish between “custom-made” and “ready-to-
wear” (or norm-based) choices. A custom-made choice involves the GP undertaking a careful
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evaluation of the patient and then matching her to an appropriate product. However, as new
products are introduced, GPs face considerable costs in the process of gaining the knowledge
and expertise required to discuss and prescribe these products. This is particularly the case
when more familiar products are available even though they may be somewhat inferior to the
new products; an especially salient situation in the market for contraceptive products. In such
cases, some GPs will tend to adopt norms (here particular products) that work well for a broad
class of patients and to place less weight on certain patient attributes that would indicate a
different product that is potentially a better match.
Particular interest is in the dependence between the products. That is, which products
tend to be discussed together and which tend to form distinct clusters. If GPs pursue custom-
made strategies, then a considerable portion of the dependence between products will be
explained by the attributes of the patient. Conditional on the observable features of the patient
and characteristics of the GPs, remaining dependencies will reflect the relationship between
unobservables related to evaluations of the suitability of certain products for a particular
patient, and how individual GP’s product effects are correlated across products. The proposed
model is designed to capture these forms of heterogeneity and will permit a detailed analysis
of the choices.
The prevalence of ready-to-wear choices is one possible explanation for the relatively low
uptake of long acting reversible contraceptive (LARC) methods in Australia (Black et al.,
2013). LARC methods are contraceptives that are administered less frequently than monthly
and include hormonal implants, intrauterine contraception (IUC), both hormonal and copper-
bearing, and contraceptive injections. There is increasing support for the greater use of these
more effective methods to reduce unintended pregnancies and abortion rates. In our analysis
below, we will use the model to explore a case where there is no clinical reason why at least
one of these LARC methods should not be considered for discussion by GPs. For ease of
presentation, we will use the subscripts in Table 4.1 to denote the products.
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Subscript Product
1 Combined pill
2 Mini-pill
3 Hormonal injection
4 Hormonal implant
5 Hormonal IUD
6 Vaginal ring
7 Copper IUD
8 Condom
Table 4.1: Correspondence of parameter subscripts to each female contraceptive product.
4.2 Discussion of the analysis results
We consider two different models for the data:
Model 1: y∗it = αi +Bxit + it, (4.1)
Model 2: y∗it = αi +Bxit +Czi + it, (4.2)
for i = 1, . . . , P = 162 GPs and t = 1, . . . , T = 16 patients. Here αi and Czi respectively
represent GP-specific random and fixed effects with zi being a vector of GP characteristics, and
Bxit represents fixed effects of the patient. We select a horseshoe prior on β = vec(B) and
model the covariance matrix Σα of the random effects by a HIW(2,A) prior in Section 3.4
where A = (0.23, 0.23, 0.46, . . . , 0.46)>. The scale is chosen to express the prior information
that the variances of the random effects are expected to be small, with those for the pill
products being less variable compared to the non-pill alternatives. The difference between
these two models is the presence of the GP-specific fixed effects in Model 2, which explain
some of the relationships in the random effects of Model 1. Let X = (X1, . . . , XD)
> be a
vector of normal random variables with covariance matrix given by ΣX . Recall that Xi and
Xj are conditionally independent given the other random variables if the (i, j)-th entry of the
precision matrix Σ−1X is zero.
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Figure 4.1: Graphical model illustrating substantial dependence structure of the contraceptive
products in both Model 1 and 2. Edges between i and j are included if the 95% credible
interval of the marginal posterior distribution of the (i, j)-th entry of R−1 does not contain 0.
Blue edges represent positive dependence while red edges represent negative dependence. The
thickness of the edges is proportional to the strength of the dependence.
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(a) Model 1.
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(b) Model 2.
Figure 4.2: Graphical models illustrating substantial dependence structure of the GP-specific
random effects α in each model. Edges between αi and αj are included if the 95% credible
interval of the marginal posterior distribution of the (i, j)-th entry of Σ−1α does not contain 0.
Blue edges represent positive dependence while red edges represent negative dependence. The
thickness of the edges is proportional to the strength of the dependence.
Figures 4.1 and 4.2 give graphical summaries of the posterior distribution of the dependence
structures of the errors  and the random effects α1:P respectively. All graphs are obtained by
computing the 95% credible interval of the posterior distribution for each entry of R−1 and
Σ−1α , where an edge is formed between two nodes if the credible interval does not include 0.
The absence of an edge between any two nodes indicates a potential conditional independence
between the two variables given the rest. The dependence structure associated with the error
terms are the same for both models. This supports the use of the MVP model in order to
capture the complex dependencies between different products that would otherwise be ignored
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in separate univariate analyses on each product. The clique formed between (5, 7, 8) in
Figure 4.1 suggests dependence in the discussion of the hormonal IUD, the copper IUD and the
condoms. In fact, the posterior correlation between both the IUD methods (5, 7) is around
0.52 on average (see r75 in Appendix F), suggesting a high tendency of these products to
be discussed together. This also reflects that one of these IUD methods is substituted by
the other in a discussion. The pill products (1, 2) are independent of each other given the
hormonal IUD and the vaginal ring (5, 6), reflecting their use as pill alternatives dictated by
particular clinical conditions. The pair of products showing the highest level of association as
indicated by our model is between the hormonal injection and the hormonal implant (3 and 4
with a posterior correlation of 0.59). This indicates the tendency of GPs to include these two
prominent LARC products together in discussions, because they represent close substitutes to
each other for many patients.
Comparing the graphical summaries of the GP random effects for each model in Figures 4.2a
and 4.2b, we see some clear differences in the posterior structure. These arise because some
of the persistence in choices of a particular product can be explained by GP characteristics,
which in turn can mean changes in the dependence structure of the GP random effects. The
differences in the posterior structure also provide some confidence that the random effects
specification is useful in capturing important GP characteristics that are not directly observed.
For Model 2, Figure 4.2b suggests three clusters of products in which there is substantial
positive dependence. Particularly relevant is the dependence between the hormonal IUD and
the implant (α4, α5). There is positive correlation between these two LARCs, indicating the
tendency for GP attitudes (either positive or negative) to be aligned. A second cluster includes
both of the pills (α1, α2) which is consistent with these products being used as a ready-to-wear
default. GPs who are more likely to discuss the combined pill after conditioning on the patient’s
characteristic behave in a similar way when considering the mini-pill.
Our models allow us to examine posterior predictions for a range of patients. Since we
are interested in the uptake of LARC products, we specify a particular female patient where
there is no clinical reason why a LARC should not be considered for discussion. Table C.1 of
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Appendix C gives the attributes of this base-case patient. Figure 4.3 summarises the estimate
of the predictive probability of a GP discussing a particular product, where the range of
predictions shown is generated for all GPs in the sample based on Model 2. For this particular
base-case patient, there is considerable agreement amongst all GPs in the sample that the
combined pill (product 1) is one of the most suitable products to be discussed, but they have
much more variable views on the other products. Amongst the LARCs (products 3, 4, 5 and
7), the hormonal injection (product 3) and the implant (product 4) are the products which are
the most likely to be discussed, with the variability across GPs perhaps simply reflecting a
view that they are good substitutes to each other, which is in fact what we find in Figure 4.1.
GPs could indeed have consistent views about the need to discuss LARCs, as they do with the
combined pill, but they are divided on which of the LARC products to discuss. To explore
this possibility, the final column in Figure 4.3 shows the predicted probability of the GPs
discussing at least one of these two products, that is P(y3 + y4 ≥ 1). The results suggest that
the GPs will discuss either product 3 or 4 (or both) with similar probability to the combined
pill. While this joint probability does indicate a median that is similar to that of discussing
the combined pill, the variability across GPs remains much larger than that associated with
the combined pill. This evidence is consistent with the hypothesis resistance amongst some
GPs to even discuss LARCs, let alone recommending them.
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Figure 4.3: Predicted probability of a GP discussing each product for a base-case patient for
each of the 162 Australian GPs.
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4.3 Comparison of sampling schemes
Table 4.2 compares the speed and the average IACT values between the independent and
antithetic sampling schemes when estimating Model 2. The antithetic variable method generates
samples marginally faster than independent sampling because it is deterministic. Based on
the results shown, we observe an improvement of 1.52 and 3.75 times performance gain in the
mixing of the random effects α1:P and regression parameter β respectively. As a result, the
mean IACT of the latent variable y∗ is also improved. Averaging across the model parameters
θ, the antithetic sampling is around 2.62 times more efficient than independent sampling.
Scheme
Independent Antithetic
IACT(y∗) 3.0417 2.2750
IACT(β) 14.7759 3.9398
IACT(vechL(L)) 11.2932 11.2729
IACT(vechL(R)) 9.8959 9.7187
IACT(diag(Σα)) 23.1953 15.2198
IACT(vechL(Rα)) 9.3601 5.0146
IACT(θ) 13.6675 5.2144
Time per iteration 0.0532 0.0531
Table 4.2: Comparison of the performance between independent and antithetic sampling in
the contraceptive products preference data in terms of the speed (seconds per iteration) and
the mean IACT taken over each block of model parameter.
5 Conclusion
Many methods exist for fitting a multinomial logit model with random effects, such as simulated
maximum likelihood (Gong et al., 2004), quadrature (Hartzel et al., 2001; Hedeker, 2003),
multinomial-Poisson transformation (Lee et al., 2017), and moment-based estimation (Perry,
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2017), among others. Computational strategies for the MVP model, on the other hand, are
less well studied. Recent advances in the Bayesian estimation of the MVP model has seen
the emergence of the parameter expansion strategy (Liu and Wu, 1999; van Dyk and Meng,
2001) as a mainstream technique in sampling the high dimensional correlation matrix R.
However, based on the empirical results in our paper, the extension of the parameter expansion
technique to the setting of the MVP panel data model is non-trivial. As an alternative, we
introduce a HMC sampling approach to generate the posterior samples of R. This method
requires reparameterising R into an unconstrained Cholesky factor in order to circumvent the
restrictive properties of a correlation matrix having diagonal entries of 1 and being positive
definite. Furthermore, we propose a novel antithetic variable technique to accelerate the mixing
of the random effects and the regression parameters, where significant gains in efficiency are
observed in our application. Although our antithetic sampling deterministically specifies the
proposal distribution within the Metropolis-Hastings update, the ergodicity of the Markov
chain is unaffected when it is embedded within a larger system of stochastic updates.
Our application looked at the discussion of female contraceptive products by Australian
GPs based on outcomes from the second stage of the stated preference data from Fiebig et al.
(2017). An examination of the correlation matrix underlying the choices revealed a complex
dependence structure between the products, hence indicating the plausibility of our formulation
to model these choices in a multivariate setting. Our empirical study also suggested evidence
of medical practice variation among the GPs, especially with regard to the inclusion of LARCs
in the discussion with patients. The combined pill was the most popular contraceptive choice
among the patients, and it represented a likely ready-to-wear default for many GPs. Without
GPs even discussing LARCs, their uptake was likely to remain relatively constrained in such a
context.
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A Parameter expansion for the MVP model
We first describe the parameter expansion (PX) strategy in Talhouk et al. (2012) for the MVP
model based on the marginally uniform prior on R of Barnard et al. (2000). We then illustrate
the extension of this method to the panel data setting where the resulting sampler fails to
converge to the correct posterior distribution.
Consider the MVP model as in Section 2, but without the random effects,
y∗i = Bxi + i, (A.1)
i = (1,i, . . . , D,i)
> iid∼ N (0,R), (A.2)
for i = 1, . . . , n. The posterior density of interest given the set of observed discrete outcomes
y = (y1, . . . ,yn) and prior distribution p(B,R) is
pi(y∗,B,R|y) ∝ p(y|y∗,B,R)p(y∗|B,R)p(B,R). (A.3)
By taking advantage of the non-identifiability of the regression parameter B when R is
not set to be a correlation matrix, Talhouk et al. (2012) introduce an expansion parameter
D = diag(δ1, . . . , δD) and define a new set of latent variables z∗i = Dy∗i , i = 1, . . . , n such that
the posterior density under this transformation is
pi(z∗,B,R,D|y) ∝ p(y|z∗,B,R,D)p(z∗|B,R,D)p(B,R,D), (A.4)
where z∗ = (z∗1 , . . . ,z
∗
n). The marginal posterior distribution of (B,R) in (A.4) is the same as
(A.3) provided that the marginal prior of p(B,R,D) is p(B,R). Using the prior distribution
on R in (2.8) with ν = D + 1 and choosing
δ2i
iid∼ IG((D + 1)/2,R−1 (i, i)/2), (A.5)
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where R−1 (i, i) is the i-th diagonal entry of R, the covariance matrix Σ = DRD is shown
to have an IW(D + 1, I) distribution. With this reparameterisation of the constrained R
into an unconstrained Σ, posterior sampling from the conditional posterior distribution
pi(B,R,D|z∗,y) can be circumvented by a change of variables technique. That is, by letting
Σ = DRD and γ = DB, iterates from the posterior distribution in (A.3) can be obtained
by the following steps:
1. Sample y∗ from a truncated multivariate normal distribution (Step 1 in Appendix B).
2. Sample D following (A.5) and set z∗i = Dy∗i , i = 1, . . . , n.
3. Sample (γ,Σ) ∼ pi(γ,Σ|z∗,y).
4. Set B = D∗γ,R = D∗ΣD∗ and y∗i = D∗z∗i , i = 1, . . . , n where D∗ = diag(Σ)−1/2.
The posterior density of the MVP model with random effects in (2.1)–(2.4), on the other
hand, is
pi(y∗,B,R,α1:P ,Σα|y) ∝p(y|y∗,B,R,α1:P ,Σα)×
p(y∗|B,R,α1:P ,Σα)p(α1:P |Σα)p(B,R,Σα).
(A.6)
Following Talhouk et al. (2012), we define new sets of latents variables z∗it = Dy∗it and
wi = Dαi for i = 1, . . . , P and t = 1, . . . , T , which gives the new posterior density as
pi(z∗,B,R,w1:P ,Σα,D|y) ∝p(y|z∗,B,R,w1:P ,Σα,D)p(z∗|B,R,w1:P ,Σα,D)×
p(w1:P |Σα,D)p(B,R,Σα,D),
(A.7)
where z∗ = (zit; i = 1, . . . , P, t = 1, . . . , T ) and w1:P = (w1, . . . ,wP ). Assuming a conjugate
prior on Σα, we then generate the samples from the posterior distribution in (A.7) by a change
of variables (Σ = DRD and γ = DB) according to
1. Sample y∗ from a truncated multivariate normal distribution (Step 1 in Appendix B).
2. Sample α1:P from a multivariate normal distribution (Step 4 in Appendix B).
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3. Sample Σα from an inverse-Wishart distribution (Step 6 in Appendix B).
4. Sample D following (A.5) and set z∗it = Dy∗it and wi = Dαi for i = 1, . . . , P and
t = 1, . . . , T .
5. Sample (γ,Σ) ∼ pi(γ,Σ|z∗,y).
6. Set B = D∗γ,R = D∗ΣD∗ and y∗it = D∗z∗it, i = 1, . . . , P, t = 1, . . . , T where D∗ =
diag(Σ)
−1/2.
We choose the conjugate matrix normal prior on B, the marginally uniform prior in (2.8) on
R and the hierarchical inverse-Wishart prior on Σα. Kernel density plots comparing the
posterior distribution of the variance parameter in Σα between the HMC algorithm and the
parameter expansion technique are given in Figure A.1. Using the posterior distribution from
the HMC algorithm as a benchmark, we notice that the parameter expansion method tends to
overestimate the variance of the random effects and the posterior densities are flatter. The
observed differences are due to the PX technique, not the choice of kernel density bandwidth.
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Figure A.1: Kernel density plots comparing the posterior density of the variance parameter
σ2αi in Σα between the HMC algorithm (blue solid) and the parameter expansion technique
(red dashed).
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B Antithetic sampling scheme for the MVP model
with random effects
Suppose that we choose the following prior distributions: β ∼ N (0,Ψβ),Σα ∼ HIW(λ,A)
and the prior distribution on the lower triangular Cholesky factor L in (3.4). Let θ =
(β, vechL(L),Σα). Equation (2.6) gives the posterior distribution of interest under the data
augmentation approach where we update y∗,α1:P and each component of θ using Gibbs
sampling. For notational clarity, we will drop the superscript which indicates the sequence of
the samples in a Markov chain where necessary.
Step 1: Updating y∗
For d = 1, . . . , D, sample
y∗d,it|α1:P ,θ,y∗−d,it, yd,it ∼

T N (−∞,0](µ(d|−d)d,it , σ(d|−d)d,it ) if yd,it = 0
T N (0,∞)(µ(d|−d)d,it , σ(d|−d)d,it ) if yd,it = 1
where y∗−d,it = (y1,it, . . . , yd−1,it, yd+1,it, . . . , yD,it)
>, µ(d|−d)d,it and σ
(d|−d)
d,it are the univariate d-th
dimension conditional mean and conditional standard deviation respectively for the N (µit,R)
distribution and T N (a,b) is a univariate normal distribution truncated to the interval (a, b).
Step 2: Updating β
Compute the posterior mean µβ and the posterior covariance matrix Σβ for β
Σβ =
(
P∑
i=1
T∑
t=1
(I ⊗ xit)R−1 (I ⊗ xit)> + Ψ−1β
)−1
,
µβ = Σβ
(
P∑
i=1
T∑
t=1
(I ⊗ xit)R−1 (y∗it −αi)
)
,
where ⊗ denotes the Kronecker product and set β[j+1] = 2µβ − β[j] deterministically. If a
horseshoe prior is specified on β, the update of the parameter can also be implemented via
Gibbs sampling (see Makalic and Schmidt (2016) for details).
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Step 3: Updating vechL(L)
Sample vechL(L) using the HMC algorithm and obtain the correlation matrix R from the
relationship in (3.2).
Step 4: Updating α1:P
For i = 1, . . . , P , compute the posterior mean µαi and the posterior covariance matrix Σ˜α for
the random effects αi
Σ˜α =
(
TR−1 + Σ
−1
α
)−1
,
µαi = Σ˜α
(
R−1
T∑
t=1
y∗it −Bxit
)
,
and set α
[j+1]
i = 2µαi −α[j]i deterministically.
Step 5: Updating a
For i = 1, . . . , D, sample
ai ∼ IG
(
λ+D
2
, λΣ−1α (i; i) +
1
A2i
)
,
where Σ−1α (i; i) is the i-th diagonal entry of the precision matrix Σ
−1
α .
Step 6: Updating Σα
Sample
Σα ∼ IW
(
λ+ P +D − 1,
P∑
i=1
αiα
>
i + 2λdiag
(
1
a1
, . . . ,
1
aD
))
.
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C Attributes of the patient in the Australian GP data
Attribute Variable Description
Age
dagegp1 Aged 16-19 years
dagegp2 Aged 20-29 years
dagegp3 Aged 30-39 years
dagegp4 Aged 40 years or more
Reason for encounter
drfe1 Starting prescribed contraception for first time
drfe2 Recommencing prescribed contraception
drfe3 On pill but dissatisfied
drfe4 Using non-pill method but dissatisfied
Periods
dbleed1 Heavy and/or painful periods
dbleed2 Irregular periods
dbleed3 No problems with periods
Blood pressure
dbp1 Has low blood pressure
dbp2 Has normal blood pressure
dbp3 Elevated blood pressure
Relationship
drel1 In long-standing relationship
drel2 In new relationship
drel3 Has no steady relationship
drel4 No information about relationship
Children
dchild1 Is currently breastfeeding
dchild2 Has children but is not breastfeeding
dchild3 Has no children
Fertility plans
dfut1 Does not want to have children in future
dfut2 Plans to have children in next 2 years
dfut3 Plans to have children but not in next 2 years
dfut4 Unsure about future fertility plans
Pill preference
dpil1 Prefer pill to other methods
dpil2 Has no strong opinion about pill
dpil3 Prefers methods other than pill
Weight concern
dwt1 Is concerned about gaining weight
dwt2 Is not concerned about gaining weight
Compliance
dcomp1 Has no difficulty with compliance
dcomp2 Has difficulty with compliance
Income
dpay1 Has a low to middle household income
dpay2 Has a health care card
dpay3 Has a high household income
Smoking
dsmk1 Is a non-smoker
dsmk2 Smokes less than 10 cigarettes per day
dsmk3 Smokes 10 or more cigarettes per day
Table C.1: Categorical variables in the contraceptive discussion data with a text description
for each level of attribute. Levels in grey define the attributes of a base-case patient.
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D Posterior means of the patient fixed effects in the
Australian GP data
Variable
Product
1 2 3 4 5 6 7 8
Intercept 1.4026 -1.2448 -0.3887 1.1099 -2.4041 -0.1309 -1.7113 0.6777
dagegp1 0.1974 -0.1334 0.0110 0.0752 -0.5025 -0.0202 -0.2892 0.0644
dagegp3 -0.1309 0.0614 -0.0620 -0.0003 0.3161 -0.0032 0.0857 0.0109
dagegp4 -0.3881 0.1814 -0.2384 -0.1042 0.8045 -0.0268 0.3775 0.0017
drfe2 -0.0430 0.0008 -0.0372 -0.0140 0.0434 -0.0189 -0.0471 0.0070
drfe3 -0.2479 -0.0529 0.0285 0.0762 0.0914 0.1058 -0.0275 0.1353
drfe4 -0.0199 0.1012 -0.0094 0.0513 0.0666 0.0723 -0.0719 0.0054
dbleed1 0.0500 -0.1327 0.0604 -0.0887 0.3982 -0.0249 -0.5218 -0.2285
dbleed2 0.0163 -0.0748 0.0217 -0.0227 0.0068 0.0397 -0.0821 -0.0248
dbp1 -0.0591 0.0000 -0.0303 0.0288 0.0034 0.0306 -0.0235 -0.1427
dbp3 -0.9902 0.2436 0.0060 0.0128 0.2350 -0.2954 0.2541 0.0355
drel1 0.0426 -0.0107 -0.0933 -0.0022 0.1565 0.0293 0.0290 -0.3945
drel3 -0.0144 0.0272 -0.0206 0.0004 -0.0261 0.0086 -0.0185 0.0190
drel4 -0.0916 0.0869 0.0691 -0.0006 -0.0094 0.0285 0.0033 -0.2036
dchild1 -1.7332 1.3001 -0.0078 -0.0903 0.9163 -0.9867 0.5286 -0.0371
dchild2 -0.0462 0.0350 -0.0626 -0.0410 0.9787 -0.0504 0.5930 -0.0539
dfut1 -0.3189 -0.0043 0.1956 0.0249 0.6284 -0.0775 0.2036 -0.1144
dfut2 -0.2846 0.1912 -0.2151 -0.1990 -0.0067 0.0366 -0.1458 0.0115
dfut4 -0.3581 0.0496 0.0475 0.0106 0.2882 0.0059 0.0128 0.0312
dpil1 0.4713 0.3618 -0.0934 -0.2596 -0.0112 -0.0316 -0.0441 -0.0278
dpil3 -0.1822 -0.2448 0.0300 0.0612 0.0552 0.0351 0.0469 0.0816
dwt1 0.0815 0.0368 -0.2582 -0.0616 0.0318 0.0640 -0.0127 0.0833
dcomp2 -0.3389 -0.1969 0.2133 0.0628 0.2300 -0.0034 0.3100 -0.0164
dpay2 -0.0245 -0.0540 -0.0202 -0.0029 0.0080 0.0603 0.0072 0.0075
dpay3 0.0321 -0.0631 -0.0683 -0.0167 -0.0365 0.2909 -0.0173 -0.0046
dsmk2 -0.2666 -0.0118 -0.0266 -0.0129 -0.0038 0.0422 0.0867 0.0308
dsmk3 -0.5183 -0.0143 0.0125 0.0248 0.0144 -0.0531 0.0461 0.0332
Table D.1: Regression coefficient posterior mean estimates for the attributes of a female patient
for various products in the contraceptive discussion data. Parameters whose 90% credible
interval does not include 0 are shown in grey.
36
E Posterior means of the GP fixed effects in the
Australian GP data
Variable
Product
1 2 3 4 5 6 7 8
Female -0.0643 0.0254 -0.4392 0.0716 0.0375 0.6089 -0.4569 -0.0248
Fellow -0.0182 -0.0990 0.0682 0.0375 0.2107 0.1086 -0.1452 -0.0091
Family
planning
-0.0004 -0.0160 -0.1220 0.2292 0.0446 0.0360 -0.0321 -0.0133
Bulk-
bill
-0.0199 -0.0372 0.0425 -0.0389 -0.0594 0.0035 0.0503 0.0060
Age 0.0087 0.0079 0.0205 -0.0064 0.0176 -0.0043 0.0090 -0.0101
Australian
graduate
0.0835 0.0569 -0.0080 0.3457 0.0989 -0.2348 -0.0933 0.5586
Urban -0.0947 0.0072 0.0693 -0.0073 0.0112 0.0040 -0.0285 0.1814
Table E.1: Regression coefficient posterior mean estimates for the GP fixed effects for various
products in the contraceptive discussion data. Parameters whose 90% credible interval does
not include 0 are shown in grey.
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F Posterior means of the parameters in R
Parameter Posterior Mean 95% Credible Interval
r21 -0.1157 (-0.2058, -0.0251)
r31 -0.0502 (-0.1446, 0.0451)
r32 0.1617 ( 0.0707, 0.2506)
r41 -0.0481 (-0.1512, 0.0532)
r42 0.0454 (-0.0578, 0.1512)
r43 0.5891 ( 0.5151, 0.6577)
r51 -0.2354 (-0.3223, -0.1467)
r52 -0.0255 (-0.1203, 0.0695)
r53 0.1759 ( 0.0822, 0.2657)
r54 0.2424 ( 0.1431, 0.3398)
r61 0.4721 ( 0.3930, 0.5472)
r62 -0.2702 (-0.3572, -0.1810)
r63 0.0144 (-0.0753, 0.1038)
r64 0.0358 (-0.0646, 0.1367)
r65 -0.0695 (-0.1629, 0.0266)
r71 -0.2054 (-0.3068, -0.1028)
r72 -0.0540 (-0.1559, 0.0499)
r73 0.1849 ( 0.0810, 0.2877)
r74 0.1877 ( 0.0747, 0.2973)
r75 0.5185 ( 0.4288, 0.6016)
r76 -0.0051 (-0.1138, 0.1014)
r81 -0.0196 (-0.1147, 0.0749)
r82 -0.0491 (-0.1412, 0.0440)
r83 0.0205 (-0.0704, 0.1091)
r84 0.1044 ( 0.0059, 0.2009)
r85 -0.0788 (-0.1701, 0.0131)
r86 0.1841 ( 0.0930, 0.2753)
r87 0.2046 ( 0.1036, 0.3040)
Table F.1: Posterior mean estimates of the elements in the correlation matrix R of the errors
terms with their 95% credible intervals.
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G Posterior means of the parameters in Σα
Parameter Posterior Mean 95% Credible Interval
σ2α1 0.5147 ( 0.3630, 0.7095)
σ2α2 0.6492 ( 0.4745, 0.8690)
σ2α3 1.3021 ( 0.9554, 1.7634)
σ2α4 1.5329 ( 1.0905, 2.1402)
σ2α5 1.0586 ( 0.7785, 1.4112)
σ2α6 1.4533 ( 1.0695, 1.9627)
σ2α7 1.9449 ( 1.3741, 2.7053)
σ2α8 1.2432 ( 0.8962, 1.6945)
σ(α2,α1) 0.3009 ( 0.1813, 0.4417)
σ(α3,α1) 0.2733 ( 0.1148, 0.4542)
σ(α3,α2) 0.3026 ( 0.1314, 0.5004)
σ(α4,α1) 0.2481 ( 0.0731, 0.4489)
σ(α4,α2) 0.2659 ( 0.0681, 0.4870)
σ(α4,α3) 0.2525 (-0.0200, 0.5434)
σ(α5,α1) 0.0764 (-0.0677, 0.2272)
σ(α5,α2) 0.1866 ( 0.0322, 0.3566)
σ(α5,α3) -0.0177 (-0.2376, 0.2022)
σ(α5,α4) 0.5141 ( 0.2705, 0.8058)
σ(α6,α1) 0.2012 ( 0.0305, 0.3969)
σ(α6,α2) 0.2195 ( 0.0360, 0.4232)
σ(α6,α3) 0.1101 (-0.1427, 0.3672)
σ(α6,α4) 0.2469 (-0.0342, 0.5528)
σ(α6,α5) 0.2856 ( 0.0539, 0.5430)
σ(α7,α1) 0.0611 (-0.1420, 0.2722)
σ(α7,α2) 0.2400 ( 0.0277, 0.4768)
σ(α7,α3) 0.2573 (-0.0378, 0.5871)
σ(α7,α4) -0.2164 (-0.5979, 0.1113)
σ(α7,α5) 0.0148 (-0.2596, 0.2956)
σ(α7,α6) 0.2915 (-0.0194, 0.6297)
σ(α8,α1) 0.2570 ( 0.0982, 0.4404)
σ(α8,α2) 0.3344 ( 0.1562, 0.5423)
σ(α8,α3) 0.0750 (-0.1594, 0.3157)
σ(α8,α4) 0.2315 (-0.0290, 0.5223)
σ(α8,α5) 0.2537 ( 0.0449, 0.4889)
σ(α8,α6) 0.4904 ( 0.2432, 0.7802)
σ(α8,α7) 0.4139 ( 0.1235, 0.7563)
Table G.1: Posterior mean estimates of the elements in the covariance matrix Σα of the
random effects with their 95% credible intervals. The variance parameter in Σα is denoted by
σ2αi while the (i, j)-th covariance parameter is given by σ(αi,αj).
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